Supply Chain Defensibility: Executive insider transaction patterns and SEC Form 4 filing history for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) [Vendor Risk Profiling]
Supply Chain Defensibility: Executive insider transaction patterns and SEC Form 4 filing history for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) [Vendor Risk Profiling]
Corporate governance tracking and executive insider sentiment analytics for TEVA PHARMACEUTICAL INDUSTRIES LTD (ticker TEVA) aggregates official SEC Form 4 insider filings submitted by officers, directors, and beneficial owners holding greater than 10% equity. Independent forensic analysis examines transaction timing, direct share ownership adjustments, and option exercise executions relative to historical enterprise performance, offering a transparent window into internal leadership confidence. Supply chain vulnerability profiling examines tier-one vendor dependency ratios, component lead times, and cross-border logistics exposure under changing tariff architectures.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Is Cross | false |
| Has Whale | false |
| Has Congress | true |
| Has Contract | false |
| Darkpool Ratio | 0.6925 |
Full trading intelligence, federal contract history and congressional flow for TEVA.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.